These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 17974597)

  • 1. Psychometric properties of the Rheumatoid Arthritis Disease Activity Index (RADAI) in a cohort of consecutive Dutch patients with RA starting anti-tumour necrosis factor treatment.
    Veehof MM; ten Klooster PM; Taal E; van Riel PL; van de Laar MA
    Ann Rheum Dis; 2008 Jun; 67(6):789-93. PubMed ID: 17974597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Responsiveness of the self-assessed rheumatoid arthritis disease activity index to a flare of disease activity.
    Fransen J; Häuselmann H; Michel BA; Caravatti M; Stucki G
    Arthritis Rheum; 2001 Jan; 44(1):53-60. PubMed ID: 11212176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient-centered rheumatoid arthritis disease activity assessment by a modified RADAI.
    Leeb BF; Haindl PM; Maktari A; Nothnagl T; Rintelen B
    J Rheumatol; 2008 Jul; 35(7):1294-9. PubMed ID: 18484698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of the French version of the arthritis impact measurement scales 2 and comparison with the french version of the Nottingham Health Profile. "Quality of Life in Rheumatology" Task Force.
    Pouchot J; Guillemin F; Coste J; Brégeon C; Sany J
    Rev Rhum Engl Ed; 1996 Jun; 63(6):389-404. PubMed ID: 8817749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative responsiveness of the EuroQol-5D and Short Form 6D to improvement in patients with rheumatoid arthritis treated with tumor necrosis factor blockers: results of the Dutch Rheumatoid Arthritis Monitoring registry.
    Buitinga L; Braakman-Jansen LM; Taal E; Kievit W; Visser H; van Riel PL; van de Laar MA
    Arthritis Care Res (Hoboken); 2012 Jun; 64(6):826-32. PubMed ID: 22262513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term outcome after anti-tumor necrosis factor-alpha therapy in rheumatoid arthritis: do we need to revise our assessment criteria?
    El Miedany Y; Youssef SS; El Gaafary M
    J Rheumatol; 2006 Mar; 33(3):490-7. PubMed ID: 16511918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential novel biomarkers of disease activity in rheumatoid arthritis patients: CXCL13, CCL23, transforming growth factor alpha, tumor necrosis factor receptor superfamily member 9, and macrophage colony-stimulating factor.
    Rioja I; Hughes FJ; Sharp CH; Warnock LC; Montgomery DS; Akil M; Wilson AG; Binks MH; Dickson MC
    Arthritis Rheum; 2008 Aug; 58(8):2257-67. PubMed ID: 18668547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of variants of Fc gamma receptors IIA and IIIA on the American College of Rheumatology and European League Against Rheumatism responses to anti-tumour necrosis factor alpha therapy in rheumatoid arthritis.
    Cañete JD; Suárez B; Hernández MV; Sanmartí R; Rego I; Celis R; Moll C; Pinto JA; Blanco FJ; Lozano F
    Ann Rheum Dis; 2009 Oct; 68(10):1547-52. PubMed ID: 18930989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of internal and external responsiveness of the generic Medical Outcome Study Short Form-36 (SF-36) with disease-specific measures in rheumatoid arthritis.
    Veehof MM; ten Klooster PM; Taal E; van Riel PL; van de Laar MA
    J Rheumatol; 2008 Apr; 35(4):610-7. PubMed ID: 18322989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The rheumatoid arthritis disease activity index-5 in daily use. Proposal for disease activity categories.
    Rintelen B; Haindl PM; Sautner J; Leeb BA; Deutsch C; Leeb BF
    J Rheumatol; 2009 May; 36(5):918-24. PubMed ID: 19332635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The comparative responsiveness of the patient self-report questionnaires and composite disease indices for assessing rheumatoid arthritis activity in routine care.
    Salaffi F; Ciapetti A; Gasparini S; Carotti M; Bombardieri S;
    Clin Exp Rheumatol; 2012; 30(6):912-21. PubMed ID: 22935335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validity, reliability, and sensitivity to change of a French version of the arthritis impact measurement scales 2 (AIMS2) in patients with rheumatoid arthritis treated with methotrexate.
    Pouchot J; Guillemin F; Coste J; Brégeon C; Sany J
    J Rheumatol; 1996 Jan; 23(1):52-60. PubMed ID: 8838508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The DAS28 in rheumatoid arthritis and fibromyalgia patients.
    Leeb BF; Andel I; Sautner J; Nothnagl T; Rintelen B
    Rheumatology (Oxford); 2004 Dec; 43(12):1504-7. PubMed ID: 15252215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depression in RA patients treated with anti-TNF is common and under-recognized in the rheumatology clinic.
    Hider SL; Tanveer W; Brownfield A; Mattey DL; Packham JC
    Rheumatology (Oxford); 2009 Sep; 48(9):1152-4. PubMed ID: 19608723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Titration of infliximab treatment in rheumatoid arthritis patients based on response patterns.
    Flendrie M; Creemers MC; van Riel PL
    Rheumatology (Oxford); 2007 Jan; 46(1):146-9. PubMed ID: 16782732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of a patient-based disease activity score in rheumatoid arthritis that can be used in clinical trials and routine practice.
    Choy EH; Khoshaba B; Cooper D; MacGregor A; Scott DL
    Arthritis Rheum; 2008 Feb; 59(2):192-9. PubMed ID: 18240256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do changes in prescription practice in patients with rheumatoid arthritis treated with biological agents affect treatment response and adherence to therapy? Results from the nationwide Danish DANBIO Registry.
    Hetland ML; Lindegaard HM; Hansen A; Pødenphant J; Unkerskov J; Ringsdal VS; Østergaard M; Tarp U
    Ann Rheum Dis; 2008 Jul; 67(7):1023-6. PubMed ID: 18272669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient management of rheumatoid arthritis significantly reduces long-term functional disability.
    Tanaka E; Mannalithara A; Inoue E; Hara M; Tomatsu T; Kamatani N; Singh G; Yamanaka H
    Ann Rheum Dis; 2008 Aug; 67(8):1153-8. PubMed ID: 17971459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Responsiveness to anti-tumour necrosis factor alpha therapy is related to pre-treatment tissue inflammation levels in rheumatoid arthritis patients.
    van der Pouw Kraan TC; Wijbrandts CA; van Baarsen LG; Rustenburg F; Baggen JM; Verweij CL; Tak PP
    Ann Rheum Dis; 2008 Apr; 67(4):563-6. PubMed ID: 18042642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Responsiveness of health status measures and utility-based methods in patients with rheumatoid arthritis.
    Salaffi F; Stancati A; Carotti M
    Clin Rheumatol; 2002 Nov; 21(6):478-87. PubMed ID: 12447631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.